Mastodon

Viprosal B® (Ointment) Instructions for Use

ATC Code

M02AX10 (Other drugs)

Clinical-Pharmacological Group

Drug with local irritant and analgesic action

Pharmacotherapeutic Group

Drugs for external use for muscle and joint pain; other drugs for external use for muscle and joint pain

Pharmacological Action

A drug for external use containing viper venom. It has a local irritant and analgesic effect.

It irritates the sensitive receptors of the skin and subcutaneous tissue, dilates blood vessels, and improves tissue trophism.

Indications

  • Neuralgia;
  • Arthralgia;
  • Myositis.

ICD codes

ICD-10 code Indication
M25.5 Pain in joint
M60 Myositis
M79.1 Myalgia
M79.2 Neuralgia and neuritis, unspecified
ICD-11 code Indication
8E4A.1 Paraneoplastic or autoimmune diseases of the peripheral or autonomic nervous system
FB30 Infectious myositis
FB32 Other specified disorders of muscle
FB3Z Disorder of muscle, unspecified
FB56 Specified soft tissue diseases, not elsewhere classified
FB56.0 Granuloma of soft tissue due to foreign body, not elsewhere classified
FB56.2 Myalgia
ME82 Pain in joint

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Ointment

For external use in adults and children over 12 years of age.

Depending on the size of the skin surface, apply small portions of 5-10 g (1-2 teaspoons) of the ointment to the painful area and rub into the skin 1-2 times/day depending on the intensity of the pain until the pain syndrome disappears.

The duration of the treatment course depends on the nature and severity of the disease.

The patient should consult a doctor if the symptoms of the disease persist after a 14-day course of treatment.

Adverse Reactions

Allergic reactions itching, swelling, or urticaria.

To avoid side effects, it is recommended to first apply a small amount of the ointment to the skin to determine sensitivity to the drug.

If side effects occur, the patient should consult a doctor.

Contraindications

  • Hypersensitivity to the components of the drug.
  • Skin lesions;
  • Skin diseases (including those of allergic and bacterial origin);
  • Febrile conditions;
  • Pulmonary tuberculosis;
  • Cerebral and coronary circulation disorders;
  • Predisposition to angiospasms;
  • Severe renal impairment;
  • Severe hepatic impairment;
  • General exhaustion;
  • Children under 12 years of age;
  • Pregnancy;
  • Breastfeeding period.

Use in Pregnancy and Lactation

The drug is contraindicated for use during pregnancy and lactation (breastfeeding).

Use in Hepatic Impairment

The drug is contraindicated in severe hepatic impairment.

Use in Renal Impairment

The drug is contraindicated in severe renal impairment.

Pediatric Use

Contraindication: children under 12 years of age.

Special Precautions

If the ointment is accidentally swallowed, a doctor should be consulted.

The ointment must not be applied to damaged skin.

If accidentally applied to mucous membranes, the ointment causes severe irritation.

After applying the ointment, wash hands thoroughly to avoid getting the ointment into the eyes and on mucous membranes.

If the ointment gets into the eyes or on mucous membranes, rinse them abundantly with water.

Effect on the ability to drive vehicles and operate machinery

The use of the drug does not affect the ability to perform potentially hazardous activities requiring increased concentration and speed of psychomotor reactions (driving vehicles, working with moving machinery, work of a dispatcher and operator).

Overdose

To date, no cases of overdose with Viprosal B® have been reported.

Drug Interactions

Not described.

Storage Conditions

The drug should be stored out of the reach of children at a temperature not exceeding 25°C (77°F). Do not store in the refrigerator or freezer.

Shelf Life

The shelf life is 3 years.

Dispensing Status

The drug is available without a prescription.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Marketing Authorization Holder

Grindeks, JSC (Latvia)

Dosage Form

Bottle OTC Icon Viprosal B® Ointment for external use: tubes 30 g or 50 g

Dosage Form, Packaging, and Composition

Ointment for external use white or white with a slightly yellowish tint, with the smell of camphor or turpentine.

1 g
Vipera berus venom dried 0.05 MU*
Racemic camphor 30 mg
Turpentine gum 30 mg
Salicylic acid 10 mg

* MU – Mouse Units.

Excipients : petrolatum, cetearyl alcohol, hard paraffin, sodium cetylstearyl sulfate, glycerol, sodium chloride, purified water – up to 1 g.

30 g – aluminum tubes (1) – cardboard boxes.
50 g – aluminum tubes (1) – cardboard boxes.

Marketing Authorization Holder

Grindeks, JSC (Latvia)

Dosage Form

Bottle OTC Icon Viprosal B® Ointment for external use: tubes 30 g or 50 g

Dosage Form, Packaging, and Composition

Ointment for external use white or white with a slightly yellowish tint, with the smell of camphor or turpentine.

1 g
Vipera berus venom dry 0.05 MU*
Racemic camphor 30 mg
Turpentine gum 30 mg
Salicylic acid 10 mg

* MU – Mouse Units.

Excipients : petrolatum, cetearyl alcohol, hard paraffin, sodium cetylstearyl sulfate, glycerol, sodium chloride, purified water – up to 1 g.

30 g – aluminum tubes (1) – cardboard boxes.
50 g – aluminum tubes (1) – cardboard boxes.

Marketing Authorization Holder

Grindeks, JSC (Latvia)

Manufactured By

Tallinn Pharmaceutical Plant, JSC (Estonia)

Contact Information

GRINDEX JSC (Latvia)

Dosage Form

Bottle OTC Icon Viprosal B® Ointment for external use: 30 g, 50 g or 75 g tubes

Dosage Form, Packaging, and Composition

Ointment for external use white or white with a slightly yellowish tint, with the smell of camphor or turpentine.

1 g
Vipera berus venom dried 0.05 MU
Racemic camphor 30 mg
Turpentine gum 30 mg
Salicylic acid 10 mg

Excipients : petrolatum, cetearyl alcohol, hard paraffin, sodium cetylstearyl sulfate, glycerol, sodium chloride, purified water – up to 1 g.

30 g – aluminum tubes (1) – cardboard boxes.
50 g – aluminum tubes (1) – cardboard boxes.
75 g – aluminum tubes (1) – cardboard boxes.

TABLE OF CONTENTS